Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.6K

Short-term real-world outcomes of switching to faricimab in anti-VEGF-refractory retinal vein occlusion: a

Adnan Kilani1, Denise Vogt2, Efstathios Vounotrypidis2

  • 1Department of Ophthalmology, Ulm University Hospital, Prittwitzstraße 43, 89075, Ulm, Germany. adnan.kilani@uniklinik-ulm.de.

BMC Ophthalmology
|February 27, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Angiopoietin-2/VEGF-A inhibitorAnti-VEGF therapyReal-world dataRetinal vein occlusionsSecondary macular edema

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

9.4K
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

8.4K

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.6K
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

9.4K
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

8.4K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K

Articles linked to this work by shared authors, journal, and citation graph.

Diabetic cataract at type 1 diabetes onset: frequency and characteristics.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Switching to faricimab in anti-VEGF-refractory retinal vein occlusion: nine-month prospective real-world outcomes under a modified treat-and-extend regimen.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Retinal glial cell removing during internal limiting membrane peeling is associated with higher-stage idiopathic epiretinal membrane.

Eye and vision (London, England)·2026

Oral belzutifan treatment in von hippel-lindau-associated retinal hemangioblastoma: a promising approach.

International journal of retina and vitreous·2026

Infants with retinopathy of prematurity (ROP) in Germany and Türkiye-a comparison based on data from the EU-ROP registry.

Frontiers in medicine·2026

Kahook Dual Blade: six-month results in uncontrolled open angle glaucoma.

International journal of ophthalmology·2026

Layer-specific retinal microvascular redistribution in children with severe adenotonsillar hypertrophy assessed by optical coherence tomography angiography.

BMC ophthalmology·2026

Visual, refractive and patient-reported outcomes after two trifocal intraocular lens designs: a 12-month comparative cohort study.

BMC ophthalmology·2026

Pars plana vitrectomy under air infusion versus conventional fluid infusion for dense vitreous hemorrhage: a retrospective comparative study.

BMC ophthalmology·2026

Motor alignment and sensory outcomes in pediatric patients with basic-type intermittent exotropia after bilateral lateral rectus recession versus unilateral recession-resection.

BMC ophthalmology·2026

Effects of systemic isotretinoin therapy on tear function and choroidal thickness in nodulocystic acne patients: a prospective comparative study.

BMC ophthalmology·2026

Intravitreal methotrexate as a prophylactic strategy for proliferative vitreoretinopathy in high-risk retinal detachment.

BMC ophthalmology·2026

Hybrid exosome-liposome nanovesicles as delivery platforms for therapeutic applications: merging the best of both worlds.

Theranostics·2026

A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation.

Theranostics·2026

An inducible human LDLR transgenic mouse model for enhanced lentiviral gene delivery to murine immune cells.

Frontiers in immunology·2026

Transcranial ultrasound stimulation of the right globus pallidus interna in schizophrenia: A randomized, sham-controlled pilot study.

NPJ acoustics·2026

Case report: Clinical utility and limitations of high-frequency ultrasound for monitoring sonidegib response in nodular basal cell carcinoma: a three-case series.

Frontiers in oncology·2026

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

Haematologica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us